Early experiences of independent advocates for potential HIV+ recipients of HIV+ donor organ transplants

Juli M. Bollinger, Ann Eno, Shanti Seaman, Diane Brown, Sarah E. Van Pilsum Rasmussen, Aaron A Tobian, Dorry Segev, Christine Durand, Jeremy Sugarman

Research output: Contribution to journalArticle

Abstract

Background: HIV+ to HIV+ solid organ transplants in the United States are now legally permitted. Currently, these transplants must adhere to the HIV Organ Policy Equity (HOPE) Act Safeguards and Research Criteria that require the provision of an independent recipient advocate, a novel requirement for solid organ transplant programs. The objective of this study was to understand the experiences of the first advocates serving in this role. Methods: We conducted semi-structured interviews with 15 HOPE independent recipient advocates (HIRAs) from 12 institutions. Results: All HIRAs had a professional degree and experience in transplantation or infectious diseases. HIRAs' encounters with potential recipients varied in length, modality, and timing. The newness of the role and the lack of guidance were associated with unease among some HIRAs. Some questioned whether their role was redundant to others involved in transplantation and research since some potential recipients experienced informational fatigue. Conclusions: HOPE independent recipient advocates are ensuring the voluntariness of potential participants’ decision to accept an HIV-infected organ. Many suggested additional guidance would be helpful and alleviate unease. Concerns about potential role redundancy raise the question of whether the HIRA requirement may be inadvertently increasing burden for potential recipients. Future work that captures the experiences of potential recipients is warranted.

Original languageEnglish (US)
Article numbere13617
JournalClinical Transplantation
DOIs
StatePublished - Jan 1 2019

Fingerprint

HIV
Transplants
Transplantation
Research
Fatigue
Communicable Diseases
Interviews

Keywords

  • acquired immunodeficiency syndrome
  • care delivery
  • ethics
  • infection and infectious agents
  • organ procurement and transplantation network
  • patient safety
  • quality of care
  • viral: human immunodeficiency virus

ASJC Scopus subject areas

  • Transplantation

Cite this

Early experiences of independent advocates for potential HIV+ recipients of HIV+ donor organ transplants. / Bollinger, Juli M.; Eno, Ann; Seaman, Shanti; Brown, Diane; Van Pilsum Rasmussen, Sarah E.; Tobian, Aaron A; Segev, Dorry; Durand, Christine; Sugarman, Jeremy.

In: Clinical Transplantation, 01.01.2019.

Research output: Contribution to journalArticle

@article{5b36cb59c6994401b056076c006a7987,
title = "Early experiences of independent advocates for potential HIV+ recipients of HIV+ donor organ transplants",
abstract = "Background: HIV+ to HIV+ solid organ transplants in the United States are now legally permitted. Currently, these transplants must adhere to the HIV Organ Policy Equity (HOPE) Act Safeguards and Research Criteria that require the provision of an independent recipient advocate, a novel requirement for solid organ transplant programs. The objective of this study was to understand the experiences of the first advocates serving in this role. Methods: We conducted semi-structured interviews with 15 HOPE independent recipient advocates (HIRAs) from 12 institutions. Results: All HIRAs had a professional degree and experience in transplantation or infectious diseases. HIRAs' encounters with potential recipients varied in length, modality, and timing. The newness of the role and the lack of guidance were associated with unease among some HIRAs. Some questioned whether their role was redundant to others involved in transplantation and research since some potential recipients experienced informational fatigue. Conclusions: HOPE independent recipient advocates are ensuring the voluntariness of potential participants’ decision to accept an HIV-infected organ. Many suggested additional guidance would be helpful and alleviate unease. Concerns about potential role redundancy raise the question of whether the HIRA requirement may be inadvertently increasing burden for potential recipients. Future work that captures the experiences of potential recipients is warranted.",
keywords = "acquired immunodeficiency syndrome, care delivery, ethics, infection and infectious agents, organ procurement and transplantation network, patient safety, quality of care, viral: human immunodeficiency virus",
author = "Bollinger, {Juli M.} and Ann Eno and Shanti Seaman and Diane Brown and {Van Pilsum Rasmussen}, {Sarah E.} and Tobian, {Aaron A} and Dorry Segev and Christine Durand and Jeremy Sugarman",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/ctr.13617",
language = "English (US)",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Early experiences of independent advocates for potential HIV+ recipients of HIV+ donor organ transplants

AU - Bollinger, Juli M.

AU - Eno, Ann

AU - Seaman, Shanti

AU - Brown, Diane

AU - Van Pilsum Rasmussen, Sarah E.

AU - Tobian, Aaron A

AU - Segev, Dorry

AU - Durand, Christine

AU - Sugarman, Jeremy

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: HIV+ to HIV+ solid organ transplants in the United States are now legally permitted. Currently, these transplants must adhere to the HIV Organ Policy Equity (HOPE) Act Safeguards and Research Criteria that require the provision of an independent recipient advocate, a novel requirement for solid organ transplant programs. The objective of this study was to understand the experiences of the first advocates serving in this role. Methods: We conducted semi-structured interviews with 15 HOPE independent recipient advocates (HIRAs) from 12 institutions. Results: All HIRAs had a professional degree and experience in transplantation or infectious diseases. HIRAs' encounters with potential recipients varied in length, modality, and timing. The newness of the role and the lack of guidance were associated with unease among some HIRAs. Some questioned whether their role was redundant to others involved in transplantation and research since some potential recipients experienced informational fatigue. Conclusions: HOPE independent recipient advocates are ensuring the voluntariness of potential participants’ decision to accept an HIV-infected organ. Many suggested additional guidance would be helpful and alleviate unease. Concerns about potential role redundancy raise the question of whether the HIRA requirement may be inadvertently increasing burden for potential recipients. Future work that captures the experiences of potential recipients is warranted.

AB - Background: HIV+ to HIV+ solid organ transplants in the United States are now legally permitted. Currently, these transplants must adhere to the HIV Organ Policy Equity (HOPE) Act Safeguards and Research Criteria that require the provision of an independent recipient advocate, a novel requirement for solid organ transplant programs. The objective of this study was to understand the experiences of the first advocates serving in this role. Methods: We conducted semi-structured interviews with 15 HOPE independent recipient advocates (HIRAs) from 12 institutions. Results: All HIRAs had a professional degree and experience in transplantation or infectious diseases. HIRAs' encounters with potential recipients varied in length, modality, and timing. The newness of the role and the lack of guidance were associated with unease among some HIRAs. Some questioned whether their role was redundant to others involved in transplantation and research since some potential recipients experienced informational fatigue. Conclusions: HOPE independent recipient advocates are ensuring the voluntariness of potential participants’ decision to accept an HIV-infected organ. Many suggested additional guidance would be helpful and alleviate unease. Concerns about potential role redundancy raise the question of whether the HIRA requirement may be inadvertently increasing burden for potential recipients. Future work that captures the experiences of potential recipients is warranted.

KW - acquired immunodeficiency syndrome

KW - care delivery

KW - ethics

KW - infection and infectious agents

KW - organ procurement and transplantation network

KW - patient safety

KW - quality of care

KW - viral: human immunodeficiency virus

UR - http://www.scopus.com/inward/record.url?scp=85067429097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067429097&partnerID=8YFLogxK

U2 - 10.1111/ctr.13617

DO - 10.1111/ctr.13617

M3 - Article

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

M1 - e13617

ER -